Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-28 @ 10:22 PM
Study NCT ID:
NCT04707703
Status:
TERMINATED
Last Update Posted:
2022-11-25
First Post:
2021-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Sponsor:
Jeffrey Jenks, MD, MPH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-25
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-08
First Submit QC Date:
None
Study First Post Date:
2021-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-23
Last Update Post Date:
2022-11-25
Last Update Post Date Type:
ACTUAL